Nanjing Vishee (China) Price on September 1, 2023
| 688580 Stock | 27.26 0.11 0.40% |
Below is the normalized historical share price chart for Nanjing Vishee Medical extending back to July 21, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Nanjing Vishee stands at 27.26, as last reported on the 10th of January, with the highest price reaching 27.68 and the lowest price hitting 26.77 during the day.
If you're considering investing in Nanjing Stock, it is important to understand the factors that can impact its price. At this point, Nanjing Vishee is not too volatile. Nanjing Vishee Medical has Sharpe Ratio of 0.0076, which conveys that the firm had a 0.0076% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Nanjing Vishee, which you can use to evaluate the volatility of the firm. Please verify Nanjing Vishee's insignificant Risk Adjusted Performance, mean deviation of 2.16, and Standard Deviation of 2.9 to check out if the risk estimate we provide is consistent with the expected return of 0.022%.
As of January 10, 2025, Total Stockholder Equity is expected to decline to about 1 B. In addition to that, Common Stock Shares Outstanding is expected to decline to about 71.5 M. Nanjing Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 31.9177 | 50 Day MA 30.1942 | Beta 0.267 |
Nanjing |
Sharpe Ratio = 0.0076
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688580 |
Estimated Market Risk
| 2.9 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nanjing Vishee is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nanjing Vishee by adding Nanjing Vishee to a well-diversified portfolio.
Price Book 1.6193 | Enterprise Value Ebitda 12.8184 | Price Sales 6.0179 | Shares Float 31.5 M | Dividend Share 1.076 |
Related Headline
Jinsanjiang Silicon Headline on 1st of September 2023
Stock Market Today Dow Opens Higher After Jobs Report Tesla,... by news.google.com
Stock Market Today Dow Opens Higher After Jobs Report Tesla, Apple, and Other Premarket Movers BarronsStock Market Today Dow, SP 500 Close Lower Salesforce, Cannabis Stocks in Focus The Wall Street JournalStocks jump after surprise rise in US unemployment Stock market news today Yahoo Finance
Nanjing Vishee Valuation on September 1, 2023
It is possible to determine the worth of Nanjing Vishee on a given historical date. On September 1, 2023 Nanjing was worth 93.25 at the beginning of the trading date compared to the closed value of 61.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nanjing Vishee stock. Still, in general, we apply an absolute valuation method to find Nanjing Vishee's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nanjing Vishee where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nanjing Vishee's related companies.
| Open | High | Low | Close | Volume | |
| 93.24 | 95.65 | 63.79 | 63.79 | 1,297,616 | |
09/01/2023 | 93.25 | 94.26 | 61.76 | 61.76 | 999,837 |
| 62.21 | 63.05 | 59.98 | 60.37 | 944,366 |
| Backtest Nanjing Vishee | | | Nanjing Vishee History | | | Nanjing Vishee Valuation | Previous | Next |
Nanjing Vishee Trading Date Momentum on September 1, 2023
| On September 04 2023 Nanjing Vishee Medical was traded for 60.37 at the closing time. The highest price during the trading period was 63.05 and the lowest recorded bid was listed for 59.98 . The volume for the day was 944.4 K. This history from September 4, 2023 contributed to the next trading day price decline. The daily price change to the next closing price was 2.25% . The trading delta at closing time to the current price is 5.91% . |
Nanjing Vishee Medical Fundamentals Correlations and Trends
By evaluating Nanjing Vishee's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nanjing Vishee's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nanjing financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nanjing Vishee Stock history
Nanjing Vishee investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nanjing is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nanjing Vishee Medical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nanjing Vishee stock prices may prove useful in developing a viable investing in Nanjing Vishee
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 110.5 M | 71.5 M | |
| Net Income Applicable To Common Shares | 108 M | 113.4 M |
Nanjing Vishee Quarterly Net Working Capital |
|
Nanjing Vishee Stock Technical Analysis
Nanjing Vishee technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Nanjing Vishee Period Price Range
Low | January 10, 2025
| High |
0.00 | 0.00 |
Nanjing Vishee Medical cannot be verified against its exchange. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nanjing Vishee January 10, 2025 Market Strength
Market strength indicators help investors to evaluate how Nanjing Vishee stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nanjing Vishee shares will generate the highest return on investment. By undertsting and applying Nanjing Vishee stock market strength indicators, traders can identify Nanjing Vishee Medical entry and exit signals to maximize returns
Nanjing Vishee Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nanjing Vishee's price direction in advance. Along with the technical and fundamental analysis of Nanjing Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nanjing to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.10) | |||
| Treynor Ratio | (0.17) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Nanjing Stock analysis
When running Nanjing Vishee's price analysis, check to measure Nanjing Vishee's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanjing Vishee is operating at the current time. Most of Nanjing Vishee's value examination focuses on studying past and present price action to predict the probability of Nanjing Vishee's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanjing Vishee's price. Additionally, you may evaluate how the addition of Nanjing Vishee to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |